The novel treatment of this peptide represents a significant development in the handling of type 2 diabetes. Distinct from existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide649610.thekatyblog.com/40133417/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment